Generic Name and Formulations:
Erythromycin 3%, benzoyl peroxide 5%; gel.
Cutanea Life Sciences, Inc.
Indications for AKTIPAK:
Contents must be mixed (in the palm of the hand) prior to use. Apply to cleansed, dried areas twice daily.
Avoid eyes, mouth, mucous membranes. Discontinue if excessive irritation occurs. Avoid excessive or prolonged exposure to sunlight. Flammable. Pregnancy (Cat.C). Nursing mothers.
Additive irritation with peeling, desquamating, abrasive agents. Concomitant other topical acne products: not recommended.
Macrolide antibiotic + antibacterial/ keratolytic.
Dry skin, application site reactions (eg, stinging, erythema, burning), blepharitis, pruritus, photosensitivity, peeling, superinfection; may bleach hair or fabrics.
Gel (dual-chamber pouches, mixed by patient)—60
Endocrinology Advisor Articles
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Effect of Growth Hormone Treatment on BMD in Adults With Prader-Willi Syndrome
- Once-Daily Oral Contraceptive for Men Shows Promise
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Metformin May Improve Pregnancy Outcomes in Polycystic Ovary Syndrome
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- No Cardiovascular Benefit With Fenofibrate in T2D and Hypertriglyceridemia
- Cardiovascular Function May Improve After Cure of Cushing Syndrome
- Primary Prevention Outcomes With Aspirin in T2D and Heart Failure